ADLM 2025 Recordings - now available for purchase
Access more than 100 hours of the conference's popular and timely sessions presented at ADLM 2025. Recordings will be available for viewing through July 31, 2026.
When possible, sessions presented at ADLM 2025, held July 27 – July 31, 2025, are available as part of the ADLM 2025 Session Recordings. The listing of specific recordings included is below.
Please note that ADLM 2025 Session Recordings are not eligible for continuing education credit.
ADLM 2025 Session Recordings will be available starting September 9, 2025. Individuals that have purchased or been given complimentary access will be notified by email when the recordings are available. Access instructions will be provided at that time. Session recordings will be accessible through July 31, 2026. View purchase details.
Below is a full list of sessions. Those that may not be included in the session recordings due to speaker requests or other limitations are indicated in red. A final list of included sessions will be available by August 12.
Jump to:
11001 Global strategies to advance genomic medicine
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Heidi Rehm, PhD, FACMG, Massachusetts General Hospital , Broad Institute of MIT and Harvard, Cambridge, MA
62001 Global strategies to advance genomic medicine (Meet-the-expert)
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Heidi Rehm, PhD, FACMG, Massachusetts General Hospital , Broad Institute of MIT and Harvard, Cambridge, MA
12001 Artificial intelligence in real world clinical settings
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Judy Wawira Gichoya, MD, MS , FSIIM, Emory University, Atlanta, GA
13001 Infodemic! Is misinformation killing us?
(permission withheld by speaker)
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Timothy Caulfield, CM, LLM, FRSC, FCAHS, University of Alberta, Edmonton, AB, Canada
14001 Precision microbiome medicine: Identifying diagnostics and treatments
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Jack Gilbert, PhD, UC San Diego, UCSD Microbiome and Metagenomics Center, La Jolla, CA
15001 The urgent threat of plastics to human health, and what we can do about it
Moderator: Gwendolyn McMillin, PhD, DABCC, FADLM, University of Utah/ARUP Laboratories, Salt Lake City, UT
Speaker(s): Leonardo Trasande, MD, MPP, NYU Grossman School of Medicine, New York, NY
12002 Disruptive Technology Award Competition
Moderator: Stephen Master, MD, PhD, FADLM, Children's Hospital of Philadelphia
Speaker(s):
Brendan Walker, MBA, Chief Executive Officer, Chemeleon
Bryce Yao, PhD, Chief Executive Officer, MagIC Lifescience
Linus Bosaeus, M.Phys, Chief Executive Officer, Rarity Bioscience
SRA-O Student Oral Presentation Competition
Moderator: Robert Nerenz, PhD, DABCC, FADLM, Medical College of Wisconsin
Speaker(s):
Automation of serum protein immunofixation electrophoresis interpretation with artificial intelligence (AI).
Hunter Miller, PhD, University of Louisville
Differential effects of chronic kidney disease on circulating concentrations of phosphorylated tau and beta amyloid Alzheimer’s Disease blood biomarkers
Chelsea Swartchick, PhD, Mayo Clinic
Clinical Implementation and Outcome Assessment of DPYD Pharmacogenomic Testing to Guide Fluoropyrimidines Dosing for Cancer Patients in Saskatchewan
Dan Zhang, MD, University of Saskatchewan
Clinical Implication of Light Chain Fragmentation in Patients with Monoclonal Gammopathies
Jack Wu, PhD, Mayo Clinic
32101 Laboratory test harmonization and standardization: The need, the roadmap, and a model example
Moderator: Anthony Killeen, MD, PhD, DABCC, FADLM, University of Minnesota
Speaker(s):
Establishing a higher order reference measurement system for standardization/harmonization of a serum apolipoprotein panel
Christa Cobbaert, PhD, EuSpLM, Leiden University Medical Center
The harmonization/standardization toolkit and implementation challenges
Greg Miller, PhD, DABCC, Virginia Commonwealth University
32102 Life-saving or redundant? 1-hour glucose to diagnose intermediate hyperglycemia and diabetes
(permission withheld by speaker)
Moderator: David Sacks, MB ChB, FRCPath, National Institutes of Health
Speaker(s):
How do we determine laboratory test cut-points for intermediate hyperglycemia and diabetes?
Edward Gregg, PhD, Royal College of Surgeons in Ireland School of Population Health
Implementing one-hour OGTT is critical to stem the global epidemic of type 2 diabetes
Michael Bergman, MD, NYU Grossman School of Medicine
We do not need another test to find those at risk; we should more broadly implement the tools we have
Elizabeth Selvin, PhD, MPH, Johns Hopkins University
32103 Advancing patient safety through global laboratory quality indicators: Insights from the IFCC model
Moderator: J Shirley Li, MD, PhD, DABCC, NRCC, FCACB, The Ohio State University Wexner Medical Center
Speaker(s):
Comparative approaches to quality indicators in laboratory medicine
J Shirley Li, MD, PhD, DABCC, NRCC, FCACB, The Ohio State University Wexner Medical Center
Overview of how international labs, particularly in Canada, are implementing the IFCC QIs, and the impact on patient outcomes
Vincent De Guire, PhD, Maisonneuve-Rosemont Hospital
The effectiveness of IFCC quality indicators in US clinical laboratories
Jonathan Genzen, MD, PhD, ARUP Laboratories
32104 Using quality assurance parameters to ensure accurate mass spectrometry results
Moderator: Joshua Hayden, PhD, DABCC, FADLM, Cleveland Clinic
Speaker(s):
Automated approaches to identifying and addressing samples that fail quality assurance metrics
Joyce Liao, PhD, DABCC, University of Washington
Manual approaches to identifying and addressing samples that fail quality assurance metrics
Joshua Hayden, PhD, DABCC, FADLM, Cleveland Clinic
32105 Turning down the volume: Current and future coping strategies for small volume specimens from babies through adults
Moderator: Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
Speaker(s):
I can’t get any more blood: What can I do?
Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
Implementation of BIG automation for TINY patients
Erin Schuler, PhD, DABCC, Cincinnati Children's Hospital Medical Center
Technical and market forces driving the march toward reduced sample volume
Susan Evans, PhD, FADLM, BioDecisions Consulting
32106 Emerging pathogens: Science, strategy, and lab readiness
Moderator: Rebekah Dumm, PhD, Washington University in St. Louis
Speaker(s):
Emerging antimicrobial resistance: A One-Health perspective
Rebekah Dumm, PhD, Washington University in St. Louis
Emerging fungal pathogens: A diagnostic perspective
Anisha Misra, PhD, Cleveland Clinic
Emerging viral pathogens: A diagnostic perspective
Benjamin Pinsky, MD, PhD, Stanford University
32107 Supporting healthy Indigenous communities through laboratory medicine and public health
Moderator: Octavia Peck Palmer, PhD, University of Pittsburgh Medical Center
Speaker(s):
Learn, serve, repeat: Laboratory medicine and public health supporting healthy Native American communities
Octavia Peck Palmer, PhD, University of Pittsburgh Medical Center
Mitigating health disparities in American Indian populations
Ronny Bell, PhD, University of North Carolina at Chapel Hill
Native Indian health and health literacy: A lab medicine case study
Ryan Dial, MCLS, MLS(ASCP)cm University of North Carolina at Chapel Hill
32108 ADLM guidance on emergency department toxicology testing: Impact on your laboratory
Moderator: Christine Snozek, PhD, DABCC, FADLM, Mayo Clinic
Speaker(s):
Case based demonstration of how the laboratory can support recreational drug testing for the emergency department
Stacy Melanson, MD, PhD, Brigham and Womens Hospital
New recommendations for toxicology testing to meet the needs of the emergency department
Patrick Kyle, PhD, ABFT, DABCC, University of Mississippi Medical Center
32109 From bench to bedside: The evidence and implementation of GFAP & UCH-L1 in TBI evaluation
Moderator: Alan Wu, PhD, University of California at San Francisco
Speaker(s):
A clinical perspective: Clinical experience following implementation of GFAP and UCH-L1 into emergency medicine practice
Frederick Korley, MD, PhD, University of Michigan
A laboratory perspective: Considerations for implementation of traumatic brain injury biomarkers
Carmen Gherasim, PhD, University of Michigan
A research perspective: Evidence supporting the clinical use of GFAP and UCH-L1 in TBI evaluation
Frank Peacock, MD, FACEP, FACC, FESC, Baylor College of Medicine
32441 Bad, better, best: Putting generative AI to the test
Moderator: T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
Speaker(s):
Background and introduction
T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
Point
Shannon Haymond, PhD, DABCC, FADLM, Ann & Robert H Lurie Children's Hospital of Chicago
Counter-point
Christopher McCudden, PhD, DABCC, FADLM, FCAC, The Ottawa Hospital General Campus
32442 Metabolic reset in the age of GLP-1 receptor agonists: Changes in metabolism beyond diabetes and weight loss
Moderator:Steven Cotten, PhD, DABCCC, FADLM, University of North Carolina at Chapel Hill
Speaker(s):
Kidney outcome trials with GLP1 receptor agonists – the FLOW trial and beyond
David Cherney, MD, PhD, FRCPC, Toronto General Hospital Research Institute
Lipid, Lipoprotein and Proteomic / Metabolic Alterations in response to GLP-1 Agonists with cardiometabolic and liver health implications
Christos Mantzoros, MD, DSc, PhD, Harvard Medical School
32443 Eliminating inequities in STIs using point of care testing: Identifying unmet needs
Moderator: Nikolina Babic, PhD, DABCC, Medical University of South Carolina
Speaker(s):
Panel discussion: Identifying the unmet needs in point-of-care testing for STI detection
Nikolina Babic, PhD, DABCC, Medical University of South Carolina
Unmet clinical needs in STI testing: Can the lab support it?
Vera Tesic, MD, MS, ABMM, University of Chicago Medicine
Unmet clinical needs in STI testing: The physician’s perspective
Aniruddha Hazra, MD, University of Chicago
32444 Update on cystatin C: Improving care with cystatin C integration into clinical practice, and practical strategies for laboratory implementation
Moderator: Amy Karger, MD, PhD, DABCC, University of Minnesota
Speaker(s):
Barriers to widespread use of cystatin C and how to overcome them
Amy Karger, MD, PhD, DABCC, University of Minnesota
Cystatin C in clinical practice: Cases from the clinic and wards
Teresa Chen, MD, MHS, UCSF
Evidence supporting the advantages of cystatin C relative to creatinine
Michael Shlipak, MD, MPH, University of California San Francisco and San Francisco VA Healthcare System
32445 Serologic testing in the age of molecular diagnostics
Moderator: Derrick Chen, MD, University of Wisconsin Health
Speaker(s):
Serologic testing in the age of molecular diagnostics: Cases part 1
Derrick Chen, MD, University of Wisconsin Health
Serologic testing in the age of molecular diagnostics: Cases part 2
Elitza Theel, PhD, ABMM, Mayo Clinic
32446 Strategies for optimizing diagnostic accuracy of thrombophilia testing in the presence of DOAC interference: Real world applications of ADLM guidance
Moderator: Zahra Shajani-Yi, PhD, DABCC, FADLM, NRCC, Labcorp
Speaker(s):
Clinical setting of thrombophilia testing and DOAC use
Louise Man, MD, University of Virginia Health
Coagulation testing in the setting of DOACs
Lindsay Bazydlo, PhD, DABCC, FADLM, University of Virginia
32447 Laboratory biomarkers for diagnosis of multiple sclerosis: The 2024 update to the McDonald criteria
Moderator: Maria Alice Willrich, PhD, DABCC, FADLM, Mayo Clinic
Speaker(s):
New biomarkers in the 2024 McDonald criteria: CSF kappa free light chains and serum neurofilament light chains
Harald Hegen, MD, Medical University of Innsbruck
Potential paths for new biomarkers implementation in the clinical laboratory: How to offer testing in alignment with the new criteria
Florian Deisenhammer, MD, Innsbruck Medical University
Traditional biomarkers for diagnosis of multiple sclerosis: oligoclonal banding and CSF IgG index tests performance
Maria Alice Willrich, PhD, DABCC, FADLM, Mayo Clinic
32448 Challenges in clinical molecular diagnostics: Assay validation, assay updates, and reimbursement
Moderator: Susan Hsiao, MD, PhD, Columbia University Medical Center
Speaker(s):
Evolution of biomarker-directed therapy for NSCLC: Implications for laboratory testing workflows
Mahesh Mansukhani, MD, Columbia University Medical Center
Overview of the New York state clinical laboratories evaluation program and its exemption to the FDA final rule
Priya Velu, MD, PhD, NewYork-Presbyterian Weill Cornell Medical Center
Reimbursement challenges in molecular diagnostics
Susan Hsiao, MD, PhD, Columbia University Medical Center
32221 Adventures in clinical decision support: Tackling orders for daily lab tests
Moderator: Ronald Jackups, MD, PhD, Washington University in St. Louis
Speaker(s):
Clinical decision support for daily lab test orders: The Barnes-Jewish Hospital experience
Ronald Jackups, MD, PhD, Washington University in St. Louis
Clinical decision support for daily lab test orders: The Massachusetts General Hospital experience
Grace Mahowald, MD, PhD, F(ACHI), Massachusetts General Hospital
32222 Contextualizing the use of race in laboratory medicine
Moderator: Sean Campbell, PhD, DABCC, FADLM, Sinai Health System
Speaker(s):
Reconsidering the Use of Race in Open Neural Tube Defect Risk Estimation
Ralph Burns, MD, University of Texas Southwestern
Absolute neutrophil count reference intervals and the Duffy null phenotype
Kelley Tipton, MPH, ECRI
32223 The role of measuring cytokines in cancer immunotherapy
Moderator: Aleksai Tikhonov, MSc, PhD, Gustave Roussey
Speaker(s):
Key cytokines in cancer immunotherapy: From biomarkers to clinical practice
Aleksai Tikhonov, MSc, PhD, Gustave Roussey
Laboratory approaches for monitoring efficacy and toxicities in cancer immunotherapy
Qing Meng, PhD, MD, DABCC, FADLM, University of Texas/MD Anderson Cancer Center
Cytokine-mediated toxicities following CAR T-Cell therapy
Caroline Diorio, MD, MSTR, FRCPC, FAAP, Children's Hospital of Philadelphia
32224 You are in Jeopardy: Effective strategies for laboratory crisis management
Moderator: Paul Jannetto, PhD, DABCC, FADLM, MT (ASCP), Mayo Clinic
Speaker(s):
Expert panel member #1
Jane Dickerson, PhD, DABCC, Seattle Children’s Hospital
Expert panel member #2
Mark Marzinke, PhD, DABCC, FADLM, John Hopkins University
Expert panel member #3
Shannon Haymond, PhD, DABCC, FADLM, Ann & Robert H Lurie Children's Hospital of Chicago
32225 What the lab reports matters: Impact of eGFR reporting on drug decisions in clinical practice
Moderator: Greg Miller, PhD, DABCC, Virginia Commonwealth University
Speaker(s):
Getting eGFR right...it starts with the lab
Greg Miller, PhD, DABCC, Virginia Commonwealth University
Consistency is key: physician perspective on using eGFR from diagnosing and staging CKD to medication dosing
Cynthia Delgado, MD, University of California, San Francisco
32226 Expand your reach: Unlocking hospital laboratory potential through outreach
Moderator: David Shiembob, MVA, C (ASCP), ARUP Laboratories
Speaker(s):
Financial considerations for outpatient and outreach testing in the hospital laboratory
David Shiembob, MVA, C (ASCP), ARUP Laboratories
Navigating outreach: Key steps for laboratory success
Christopher Rabideau, MBA, MLS, ARUP Laboratories
Trial, triumph, and takeaways: Our hospital lab’s journey building a successful outreach program
Jayne Ellenwood, MHA, MLS (ASCP), Bryan Medical Center
32227 Beyond pamphlets and brochures: Strategic marketing skills to optimize your lab’s offerings
Moderator: Frederick Strathmann, PhD, MBA, DABCC, MOBILion Systems
Speaker(s):
Differentiation in diagnostics: Leveraging laboratory experience to drive product development
Frederick Strathmann, PhD, MBA, DABCC, MOBILion Systems
Navigating investment risks in diagnostics: Leveraging market analysis for informed decisions
Lucy Hattingh, BSc, MBA, LH Consulting
32228 From data to decisions: Enhancing toxicology testing with computational approaches
Moderator: Joyce Liao, PhD, DABCC, University of Washington
Speaker(s):
A computational approach to identify interfering medications on urine drug screening assays
Nadia Ayala-Lopez, PhD, DABCC, NRCC, MLS, MT (ASCP), Labcorp
Current informatics and dashboard applications in clinical toxicology
Joyce Liao, PhD, DABCC, University of Washington
Machine learning for improving efficiency and quality of clinical drug test services
Brody Foy, DPhil, University of Washington
32229 Next generation diagnosis of adrenal disorders
Moderator: Daniel Holmes, MD, FRCPC, The University of British Columbia
Speaker(s):
Molecular analysis of adrenal mutations: Where are we now and where are going?
Runjun Kumar, MD, PhD, University of Washington
Novel approaches to mass spectrometry profiling of adrenal steroid metabolites
Anthony Maus, PhD, Mayo Clinic
33101 CCJ hot topics: Designing and implementing artificial intelligence in laboratory medicine
Moderator: Jason Park MD, PhD, DABCC Children's Medical Center
Speaker(s):
Guidelines for AI in laboratory medicine
Shannon Haymond PhD, DABCC, FADLM Ann & Robert H Lurie Children's Hospital of Chicago
Key elements for reproducible and generalizable AI research
He Sarina Yang PhD, DABCC, FADLM Weill Cornell Medicine
33102 Update on clinical assay issues: What endocrinologists will frequently ask you
Moderator:David Sacks, MB ChB, FRCPath, National Institutes of Health
Speaker(s):
Utility of salivary cortisol/cortisone in the diagnosis of adrenal insufficiency
Catherine Zhang, MD, Medical College of Wisconsin
SHBG gene polymorphisms and other caveats in testosterone assays
Bruno Lapauw, MD, PhD, Ghent University Hospital
Utility and caveats of lipoprotein measurements
Vinaya Simha, MD, Mayo Clinic
33103 Quantitating compliance for point-of-care testing: Implementation, milestones, and metrics
Moderator: Min Yu, MD, PhD, MBA, DABCC, FADLM Beth Israel Deaconess Medical Center, Harvard Medical School
Speaker(s):
Bridging gaps in PPMP compliance: Real-world challenges and lessons learned
Min Yu, MD, PhD, MBA, DABCC, FADLM Beth Israel Deaconess Medical Center, Harvard Medical School
The secret lab: How to quickly bring a point-of-care testing location into compliance
Nicholas Larkey, PhD, University of Virginia
Empowering compliance at the point of care: The role of quality indicator dashboards in driving change
Nichole Korpi-Steiner, PhD, DABCC, University of North Carolina
33104 Academy distinguished abstracts: Advancing diagnostics using new biomarkers and technologies
(partial session permission)
Moderator: Gyorgy Abel MD, PhD Beth Israel Deaconess Medical Center
Speaker(s):
Detection of bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS) throughout the United States in healthcare patient urine samples
David Schwope, PhD, Aegis Sciences Corporation
A high sensitivity rapid xylazine dipstick for clinical urine testing
Ping Wang, PhD, DABCC, FADLM, University of Pennsylvania
Comparison of the cardiac troponin I-T-C complex and cTnI and cTnT in distinguishing myocardial infarction at presentation
Yi Zhang, PhD, Mindray
Analytical validation of desorption electrospray ionization mass spectrometry imaging for classification of thyroid fine needle aspiration biopsies
Rachel DeHoog PhD Baylor College of Medicine
33105 Laboratory test showdown! Winning with laboratory stewardship
Moderator: Allison Chambliss, PhD, DABCC, FADLM, University of California, Los Angeles Health
Speaker(s):
The essential elements of a successful laboratory stewardship program
Allison Chambliss, PhD, DABCC, FADLM, University of California, Los Angeles Health
Laboratory stewardship: Winning with systematic solutions
Jane Dickerson, PhD, DABCC, Seattle Children's Hospital
Laboratory stewardship: Winning with case considerations
Allison Chambliss, PhD, DABCC, FADLM, University of California, Los Angeles Health
33106 ADLM Healthcare forum: Addressing challenges in pediatric test access and reference intervals
Moderator: Patricia Jones, PhD, DABCC, FADLM, Children's Medical Center
Speaker(s):
Expanding access to pediatric testing
Joe Wiencek, PhD, DABCC, FADLM, NRCC, Vanderbilt University School of Medicine
Better care with better PRIs
Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
33107 When urine trouble and it ‘snot straightforward: Clinically relevant thresholds for workup of urine and respiratory cultures
Moderator: Sophonie Oyeniran, PhD, Nationwide Children's Hospital
Speaker(s):
Ur-ine or you ur-out? Clinically relevant thresholds for urine culture workup
Melanie Yarbrough, PhD, DABCC, ABMM, Washington University in St. Louis School of Medicine
Snot straightforward: Culture interpretation of respiratory specimens
Sophonie Oyeniran, PhD, Nationwide Children's Hospital
33108 How hematologists, laboratorians, and transfusion medicine physicians partner to diagnose, manage, and support patients with sickle cell disease
Moderator: Zahra Shajani-Yi, PhD, DABCC, FADLM, NRCC, Labcorp
Speaker(s):
The hematologist’s view: Clinical and hematological effects of sickle cell disease
Susanna Curtis, MD, PhD, Icahn School of Medicine at Mount Sinai
The laboratory view: Laboratory methods used to diagnose and manage sickle cell disease
Sean Campbell, PhD, DABCC, FADLM, Sinai Health System
The transfusion medicine physician’s view: Transfusion, apheresis and Gene therapy in SCD care
Jay Raval, MD, University of Vermont
33109 Practical considerations in evaluating screening and confirmation urine drug tests: Fentanyl as an example
Moderator: Rongrong Huang, PhD, DABCC, Baylor College of Medicine
Speaker(s):
Analytical evaluation and clinical consideration for implementation of urine fentanyl screening test: Core lab immunoassays vs point-of-care testing
Rongrong Huang, PhD, DABCC, Baylor College of Medicine
Analytical and clinical challenges of fentanyl testing by mass spectrometry: The reference laboratory perspective
Jessica Boyd, PhD, DABCC, University of Utah/ARUP Laboratories
Clinical utility of untargeted mass spectrometry in assessing fentanyl positivity: A tertiary hospital's perspective
Carmen Gherasim, PhD, University of Michigan
33221 A practical guide to remote sampling: Regulatory and technical considerations for successful implementation of microsampling devices in the clinical laboratory
(permission withheld by speaker)
Moderator: Erin Schuler, PhD, DABCC, Cincinnati Children's Hospital Medical Center
Speaker(s):
Regulatory considerations and best practices for evaluating and validating capillary microsampling devices
Bradley Collier, PhD, Labcorp
Successful applications of microsampling devices in the real-world
Kenneth Setchell, PhD, FAASLD, Cincinnati Children's Hospital Medical Center
Practical aspects of remote sampling and analysis: The technical dos and don’ts
Junfang Zhao, PhD, Cincinnati Children's Hospital Medical Center
33222 Federal oversight of LDTs: Where we are and where we’re going
Moderator: Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
Speaker(s):
How US Congress may respond to the court decision on LDTs
Christina Lockwood, PhD, ABMG, DABCC, University of Washington
What the LDT ruling does and doesn’t answer
Jonathan Genzen, MD, PhD, ARUP Laboratories
33223 Role of component resolved testing in food allergies: From peanuts to tick-borne red meat allergies
Moderator: Patricia Slev, PhD, DABCC, ARUP Laboratories/University of Utah
Speaker(s):
Component resolved testing in food allergies: Concept and application
Abdulrahman Saadalla, MD, MBBBCh, ARUP Laboratories
Alpha-gal component testing: A reference laboratory experience
Patricia Slev, PhD, DABCC, ARUP Laboratories/University of Utah
33224 You did what now? Addressing questionable laboratory practices
Moderator: Jacqueline Hubbard, PhD, DABCC, Beth Israel Deaconess Medical Center
Speaker(s):
When quality assurance metrics go unchecked in the clinical lab
Jacqueline Hubbard, PhD, DABCC, Beth Israel Deaconess Medical Center
The importance of LIS Validation: How garbled lab results can lead to patient harm
Grace Williams, PhD, Virginia Commonwealth University
How retrospective analysis can reveal quality and compliance issues
Aaron Geno, PhD, DABCC, Dartmouth Health
33225 The compliance detective: Finding errors before they become issues
Moderator: T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
Speaker(s):
Compliance problems in the core laboratory
T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
Compliance problems in the clinical microbiology laboratory
Robin Chamberland, PhD, ABMM, SSM Health/Saint Louis University
33226 The dilemma of bad testing: Is something better than nothing?
(permission withheld by speaker)
Moderator: Jeff Meeusen, PhD, DABCC, Mayo Clinic
Speaker(s):
Prioritizing quality: Navigating the risks of imperfect testing
Yachana Kataria, PhD, DABCC, Boston Medical Center
Navigating “off-label” testing: Embracing imperfection
Khushbu Patel, PhD, DABCC, FADLM, Children's Hospital of Philadelphia
33227 Can changes in hematologic parameters be useful in the determination of ferritin thresholds for assessment of iron deficiency?
Moderator: Edward Wong, MD, Quest Diagnostics Inc.
Speaker(s):
Promise and perils of using ferritin as a biomarker for iron deficiency
Barry Skikne, MD, University of Kansas Medical Center
Diagnosis of iron deficiency: Assessment using changes in hematologic parameters
Robert Means Jr., MD, University of Cincinnati College of Medicine
33228 Speed sessions in lab analytics: Practical tips, tricks, and tools for operational excellence
Moderator: Deanna Franke, PhD, MT (ASCP), DABCC, Atrium Health
Speaker(s):
Track 1: Leveraging data analytics to uncover preanalytical lab issues: Case study on supply chain innovation and impact on hemolysis
Kathryn Zwolenik, , University of Pittsburgh Medical Center
Track 2: Analytics case study using lab middleware: Driving turn around time improvements in core chemistry lab
Jina Forys, MBA, MLS (ASCP), University of Minnesota Medical Center
Track 3: Using beaker data to improve laboratory specimen quality: A case study on specimen labeling and blood culture collection
Ashley Vernatter, MLS (ASCP), Atrium Health
Track 4: Peeling back the onion on patient safety events: Root cause analysis from reporting point to process improvement initiatives
Jori Zinuticz, MLS(ASCP), Advocate Consolidated Laboratories (ACL)
34101 Addressing metabolic risk for specialized populations with novel laboratory medicine tools
Moderator: Jing Cao, PhD, DABCC, FADLM, University of Texas Southwestern Medical Center
Speaker(s):
Innovative risk assessment tools: Advancing cardiovascular screening in the age of metabolic dysfunction
Jeff Meeusen, PhD, DABCC, Mayo Clinic
Implementing timely cardiovascular risk screening for special patient population: Experience from a pediatric hospital
Sridevi Deveraj, PhD, DABCC, FADLM, FRSC, Baylor College of Medicine
Critical insights into cardiac marker interpretation and new technologies for patients with renal comorbidities
Allan Jaffe, MD, Mayo Clinic
34102 Improving laboratory analysis and continuous glucose monitoring (CGM) quality to optimize diabetes therapy
Moderator: James Nichols, PhD, DABCC, FADLM, Vanderbilt University Medical Center
Speaker(s):
Is there a beneficial impact of laboratory analyses on the clinical management of diabetes mellitus?
Peter Luppa, MD, amedes MVZ fuer Labormedizin und Mikrobiologie
How to overcome current challenges to ensure analytical quality in continuous glucose monitoring (CGM)
Guido Freckmann, MD, Institut fr Diabtestechnologie Forschungs- und Entwicklungsgesellschaft mbH an der Universitt Ulm
Thinking beyond current monitoring modalities for people with diabetes
James Nichols, PhD, DABCC, FADLM, Vanderbilt University Medical Center
34103 Metabolomics for diagnosis and monitoring treatment of inborn errors of metabolism
Moderator: Matthew Henderson, PhD, FCACB, FCCMG, Newborn Screening Ontario
Speaker(s):
Beyond quadrupoles and nominal mass: Getting started with untargeted metabolomic testing in the clinical laboratory
Matthew Henderson, PhD, FCACB, FCCMG, Newborn Screening Ontario
Untargeted metabolomics to inform diagnosis of inborn errors of metabolism
Sarah Elsea, PhD, FACMG, Baylor College of Medicine
Integration of metabolomics with genomics for precise diagnosis and personalized medicine
Clara van Karnebeek, MD, PhD, Amsterdam University Medical Center
34104 JALM hot topics: Diagnostic stewardship in action! Adding laboratory medicine value and improving healthcare
Moderator: Robert Christenson, PhD, DABCC, FADLM, FACC, University of Maryland School of Medicine
Speaker(s):
Diagnostic stewardship in action!
Robert Christenson, PhD, DABCC, FADLM, FACC, University of Maryland School of Medicine
Successfully decreasing blood culture contamination using a multidisciplinary approach, metrics, and nudges
Christopher Zahner, MD, University of Texas Medical Branch
34105 Preeclampsia: Precision tools to improve prediction, enabling access in resource limited settings, and personalized medicine in special populations
(permission withheld by speaker)
Moderator: Paul Yip, PhD, DABCC, FCACB, Sunnybrook Health Sciences Centre
Speaker(s):
Updates on Predictive markers for preeclampsia diagnosis
Paul Yip, PhD, DABCC, FCACB, Sunnybrook Health Sciences Centre
Implementation of preeclampsia testing in a low-resource setting and deployment strategies to rural locations
Paul Yip, PhD, DABCC, FCACB, Sunnybrook Health Sciences Centre
Prediction and diagnosis of preeclampsia using the angiogenic biomarkers in patients with chronic kidney disease
Lei Fu, PhD, DABCC, FADLM, FCACB, Sunnybrook Health Sciences Centre
34106 Breaking down silos: Transfusion medicine, microbiology, and hematopathology intersections with clinical chemistry
Moderator: Anna Merrill, PhD, DABCC, University of Iowa
Speaker(s):
A clinical chemist’s perspective on multidisciplinary management
Anna Merrill, PhD, DABCC, University of Iowa
Intersections with hematopathology through case-based discussion
Mark Girton, MD, DABCC, University of Michigan
Intersections with transfusion medicine and clinical microbiology through case-based discussion
Meredith Parsons, MD, University of Iowa Health Care
34107 The fee-for-service payment system for lab tests: A challenge for labs, patients, physicians, and insurers
Moderator: Nikola Baumann, PhD, DABCC, Mayo Clinic
Speaker(s):
Foundations of financial competence: Costing and pricing a laboratory test
Nikola Baumann, PhD, DABCC, Mayo Clinic
The fee-for service payment system for lab tests: a challenge for patients, labs, physicians and insurers.
Michael Astion, MD, PhD, Seattle Children's Hospital
34108 CSI clinical lab: Addressing the legal implications of your clinical lab results
Moderator: Jennifer Colby, PhD, DABCC, FADLM, Premier Biotech LLC
Speaker(s):
Stoner babies and other toxicology cases with legal implications
Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University
Subpoenaed for your lab’s clinical results? How to respond
Patrick Kyle, PhD, ABFT, DABCC, University of Mississippi Medical Center
34221 Analytical approaches to preanalytical errors
Moderator: Nicholas Spies, MD, University of Utah/ARUP Laboratories
Speaker(s):
An analytical approach to monitoring preanalytical errors
Yanchun Lin, PhD, Washington University in St Louis
Leveraging biological variability to detect contaminated and mislabeled specimens
Nicholas Spies, MD, University of Utah/ARUP Laboratories
Harnessing the middleware to implement customized hemolysis limits and detect wrong tube type
Anna Merrill, PhD, DABCC, University of Iowa
34222 Population screening for type 1 diabetes: Controversies and opportunities
Moderator: William Winter, MD, FADLM, DABCC, FCAP, University of Florida
Speaker(s):
An overview of screening for, and prevention of, type 1 diabetes
William Winter, MD, FADLM, DABCC, FCAP, University of Florida
Why programs for type 1 diabetes screening should be initiated now!
Emily Sims, MD, Indiana University School of Medicine
Why programs for type 1 diabetes screening should not be initiated now!
Laura Jacobsen, MD, University of Florida
34223 Lab adventures: Mastering diagnostics through real-life cases
Moderator: Joe El-Khoury, PhD, DABCC, FADLM, Yale University
Speaker(s):
Lab adventures: Mastering diagnostics through real-life cases
Joe El-Khoury, PhD, DABCC, FADLM, Yale University
Lab adventures: Mastering diagnostics through real-life cases
Christopher Farnsworth, PhD, DABCC, FADLM, Washington University in St. Louis
Lab adventures: Mastering diagnostics through real-life cases
Reid Rosehill, MS, MT (ASCP), University of California, San Francisco Health
34224 Enhancing engagement between laboratory medicine professionals and C-suite executives
Moderator: Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
Speaker(s):
Engaging with your healthy system C-suites: Are you ready?
Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
Conversations with the C-suite leadership: Effective strategies for laboratory advocates
Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
Elevating laboratory medicine: Collaborative approaches for enhanced patient care
Christa Whitney-Miller, MD, University of Rochester Medical Center
34225 Global working groups advancing diagnostics and laboratory medicine: Achievements, gaps, and future directions
Moderator: Barbara Goldsmith, PhD, FADLM, Thomas Jefferson University Hospital
Speaker(s):
Over a decade strengthening laboratory quality in Latin America: Insights, impact, and future directions
Jessica Colon-Franco, PhD, DABCC, Cleveland Clinic
Supporting laboratory quality improvement efforts in Africa through education: The journey so far
Olajumoke Oladipo, MD, DABCC, FADLM, Penn State Milton S. Hershey Medical Center
Improving laboratory performance through education, training, and quality management: Experience from Asia-Pacific working group
Qing Meng, PhD, MD, DABCC, FADLM, University of Texas/MD Anderson Cancer Center
34226 Let’s talk about STIs, baby: Considerations for STI diagnoses and pharmacologic changes during pregnancy
Moderator: Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
Speaker(s):
What to expect when you are expecting: Navigating syphilis diagnostic algorithms in pregnant and neonatal patients
Melanie Yarbrough, PhD, DABCC, ABMM, Washington University in St. Louis School of Medicine
Putting the PrEP In pregnancy: Understanding pharmacologic changes of anti-infective drugs during the pregnant period
Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
34227 Counting the cost of inappropriate laboratory testing
Moderator: Tim Lang, PhD, FADLM, FRCPath, EuSpLM, Newcastle Upon Tyne Hospitals NHS Foundation Trust
Speaker(s):
Inappropriate testing and evidence-based laboratory medicine
Andrew Don-Wauchope, MD, MBCh, FRCP, Laverty Pathology
Counting the cost of inappropriate testing – a practical approach
Tim Lang, PhD, FADLM, FRCPath, EuSpLM, Newcastle Upon Tyne Hospitals NHS Foundation Trust
34228 Forensic toxicology case files: Uncovering the laboratory’s crucial role in investigations, patient care, and public health
Moderator: Sarah Riley, PhD, DABCC, DABTC, ABFT, FADLM, Saint Louis University
Speaker(s):
Bridging the gap: Understanding the roles of clinical and forensic laboratories in toxicology and enhancing patient care through collaborative insights
Sarah Riley, PhD, DABCC, DABTC, ABFT, FADLM, Saint Louis University
From forensics to the frontline: Case-based insights on applying forensic lab technology in clinical practice
Kara Lynch, PhD, DABCC, FADLM, University of California, San Francisco
Emerging trends in novel drug detection and clinical management of toxic exposures
Alex Krotulski, PhD, Center for Forensic Science Research and Education
35101 Large language models in laboratory medicine: Foundations, cutting-edge advances, and applications
Moderator: He Sarina Yang, PhD, DABCC, FADLM, Weill Cornell Medicine
Speaker(s):
Unveiling the foundations, principles and cutting-edge advances of large language models
He Sarina Yang, PhD, DABCC, FADLM, Weill Cornell Medicine
General medical application domains for large-language models
Mark Zaydman, MD, PhD, Washington University in St Louis
Laboratory medicine and pathology applications for large-language models
Robert Benirschke, PhD, DABCC, FADLM, Northshore University Health System
35102 Proteomics in diabetes: Development and interlaboratory transfer of LC-MS/MS assays for clinical research and patient care
Moderator: Salvatore Sechi, PhD, National Institutes of Health
Speaker(s):
Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS/MS
Andrew Hoofnagle, PhD, MD, University of Washington
Interlaboratory transfer of a combined antibody-free assay for insulin and C-peptide
Annie Moradian, PhD, Cedars-Sinai Medical Center
Multiplexed quantification of circulating proinsulin proteoforms by antibody-cocktail-based immunoaffinity enrichment and LC-MS/MS
Wei-Jun Qian, PhD, Pacific Northwest National Laboratory
35104 Approaches and assumptions in laboratory reference interval determination
Moderator: Tony Badrick, PhD, MBA, FADLM, Royal College of Pathologists of Australasia Quality Assurance Programs
Speaker(s):
The history and underlying statistics of reference intervals – it’s not what you think!
Tony Badrick, PhD, MBA, FADLM, Royal College of Pathologists of Australasia Quality Assurance Programs
Different approaches to the determination of reference intervals - direct and indirect
Daniel Holmes, MD, FRCPC, The University of British Columbia
Cases of reference intervals gone bad: TSH, ALT, and proteins
Joe El-Khoury, PhD, DABCC, FADLM, Yale University
35105 Sepsis mythbusters: The what and why of sepsis
Moderator: Robin Chamberland, PhD, ABMM, SSM Health/Saint Louis University
Speaker(s):
Where does sepsis come from? Strategies for early intervention, monitoring, and management of sepsis to optimize patient outcomes
Chiagozie Pickens, MD, Northwestern Medicine
Emerging diagnostic methods to detect sepsis
Christopher Farnsworth, PhD, DABCC, FADLM, Washington University in St. Louis
35106 Do sex differences in cardiac troponin cut-offs matter
Moderator: Kristin Aakre, MD, PhD, Haukeland University Hospital
Speaker(s):
Rapid risk prediction of non-ST elevation myocardial infarction in the Emergency Department: Should we use sex-specific cut offs
Allan Jaffe, MD, Mayo Clinic
Clinical consequences of applying sex-specific cut-offs of cardiac troponins for diagnosing myocardial infarction
Dorien Kimenai, PhD, University of Edinburgh
Long-term cardiovascular prognosis based on high sensitivity troponin concentrations: How does sex matter
Torbjorn Omland, MD, PhD, University of Oslo
Access more than 100 hours of the conference's popular and timely sessions presented at ADLM 2025. Recordings will be available for viewing through July 31, 2026.
ADLM 2025 attendees that are eligible to claim credits, must do so by October 31.